De novo acute heart failure and acutely decompensated chronic heart failure.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2015-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.3238/arztebl.2015.0298PMID 26008893PMCID PMC4452901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracorporeal life support as a bridge to bridge: a strategy to optimize ventricular assist device results.

  2015influential reference
• Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.

  2015cited by this paper
• Digoxin-associated mortality: a systematic review and meta-analysis of the literature.

  2015cited by this paper
• Ultrafiltration for the treatment of congestion: a window into the lung for a better caress to the heart.

  2014cited by this paper
• Diagnostik der systolischen und diastolischen Herzinsuffizienz

  2014cited by this paper
• Sixth INTERMACS annual report: a 10,000-patient database.

  2014cited by this paper
• Extracorporeal membrane oxygenation in cardiopulmonary disease in adults.

  2014cited by this paper
• A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

  2013cited by this paper
• Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

  2013cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Door-to-balloon time and mortality among patients undergoing primary PCI.

  2013cited by this paper
• Heart failure.

  2013cited by this paper
• Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.

  2013cited by this paper
• Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function

  2012cited by this paper
• Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

  2012cited by this paper
• Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*

  2012cited by this paper
• Intraaortic balloon support for myocardial infarction with cardiogenic shock.

  2012cited by this paper
• Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.

  2012cited by this paper
• Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.

  2012cited by this paper
• Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials.

  2011cited by this paper
• Diuretic strategies in patients with acute decompensated heart failure.

  2011cited by this paper
• Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims

  2011cited by this paper
• Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.

  2011cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• Effect of nesiritide in patients with acute decompensated heart failure.

  2011cited by this paper
• Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival

  2010cited by this paper
• Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

  2010cited by this paper
• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

  2010cited by this paper
• Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

  2010cited by this paper
• Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

  2010cited by this paper
• Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

  2010cited by this paper
• Combination of loop diuretics with thiazide-type diuretics in heart failure.

  2010cited by this paper
• Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  2009cited by this paper
• Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives.

  2009cited by this paper
• Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORI

  2009cited by this paper
• Cardiac troponin and outcome in acute heart failure.

  2008cited by this paper
• Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures

  2008cited by this paper
• Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.

  2007cited by this paper
• Clinical epidemiology of heart failure

  2007cited by this paper
• Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

  2007cited by this paper
• Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

  2007cited by this paper
• Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

  2007cited by this paper
• Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

  2006cited by this paper
• Haemodynamic and clinical effects of ularitide in decompensated heart failure.

  2006cited by this paper
• EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

  2006cited by this paper
• Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.

  2006cited by this paper
• Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

  2005cited by this paper
• In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

  2005cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis.

  2005cited by this paper
• Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.

  2003cited by this paper
• Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

  2002cited by this paper
• Diuretic Therapy and Resistance in Congestive Heart Failure

  2002cited by this paper
• One-year survival following early revascularization for cardiogenic shock.

  2001cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.

  1998cited by this paper
• Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects

  1993cited by this paper

• Unveiling the Systemic Impact of Congestion in Heart Failure: A Narrative Review of Multisystem Pathophysiology and Clinical Implications

  2025cites this paper
• Comparing acute and chronic heart failure patients: the Jordanian Heart Failure Registry (JoHFR).

  2025cites this paper
• Utilization of an undergraduate emergency department research associate program for the screening and recruitment of research subjects with heart failure into a clinical study

  2024cites this paper
• Clinical Predictive Modeling of Heart Failure: Domain Description, Models’ Characteristics and Literature Review

  2024cites this paper
• Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

  2023cites this paper
• Concomitant use of extracorporeal membrane oxygenation and percutaneous microaxial assist device support for cardiogenic shock

  2023cites this paper
• Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock

  2023cites this paper
• A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

  2021cites this paper
• Two-year prognosis of patients hospitalized with decompensated heart failure in a district general hospital.

  2021cites this paper
• Empagliflozin—A New Chance for Patients with Chronic Heart Failure

  2021cites this paper
• Risk factors for poor prognosis in heart failure with particular attention to the elderly population

  2021cites this paper
• Additive harmful effects of acute kidney injury and acute heart failure on mortality in hospitalized patients

  2021cites this paper
• Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure

  2021cites this paper
• Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value

  2021cites this paper
• A STUDY ON CLINICAL PROFILE OF THE PATIENTS WITH CONGESTIVE HEART FAILURE

  2020cites this paper
• Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?

  2020cites this paper
• Die vier Schockformen – Teil 2: kardiogener Schock

  2020cites this paper
• Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study

  2020cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• Schwerpunkt : Biomarker in der Akutmedizin

  2019cites this paper
• Arterial Hypertension and Flash Pulmonary Edema

  2019cites this paper
• Bedeutung von Biomarkern bei akuter Herzinsuffizienz

  2019cites this paper
• Bedeutung von Biomarkern bei akuter Herzinsuffizienz

  2019cites this paper
• Treatment outcome and associated factors in acute heart failure patients at Tikur Anbessa Specialized Hospital, Ethiopia

  2018cites this paper
• Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study

  2018cites this paper
• Establishment of normal reference values of NT-proBNP and its application in diagnosing acute heart failure in children with severe hand food and mouth disease

  2018cites this paper
• Acute Decompensated Heart Failure

  2018cites this paper
• In-Hospital Cardiac Death: Preventive Strategies

  2018cites this paper
• Acute Right Heart Failure

  2018influential citation
• Disnea de origen cardiaco: insuficiencia cardíaca aguda

  2018cites this paper
• From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

  2017cites this paper
• University of Groningen From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities Suthahar,

  2017cites this paper
• Effect of rosuvastatin on inflammatory factor , oxidative stress and cardiac function in patients with chronic heart failure

  2017cites this paper
• Mortalidad cardíaca intrahospitalaria: Epidemiología y estrategias de prevención

  2017cites this paper
• Effect of the renal natriuretic peptide, ularitide, alone or combined with Vasopeptidase inhibitor, Omapatrilat, on experimental volume overload-induced congestive heart failure in rats (Ularitide/Omapatrilat in Congestive Heart Failure)

  2017cites this paper
• In-hospital cardiac mortality: Epidemiology and prevention strategies

  2017cites this paper
• Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure

  2017cites this paper
• Effect of the renal natriuretic peptide, ularitide, alone or combined with Vasopeptidase inhibitor, Omapatrilat, on experimental volume overload-induced congestive heart failure in rats (Ularitide/Omapatrilat in Congestive Heart Failure)

  2017cites this paper
• In Reply.

  2016cites this paper
• The Renaissance of Digitoxin Is Overdue.

  2016cites this paper
• Chronic Heart Failure Clinical Practice Guidelines’ Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

  2016cites this paper
• Which Patients Will Benefit?

  2016cites this paper
• The Differential Diagnosis of Dyspnea.

  2016cites this paper
• Rapid Application Is Crucial.

  2016cites this paper
• An evaluation of trimetazidine as a therapeutic intervention in a newly established ex vivo mouse model of acute heart failure

  2016cites this paper
• Heart failure: an historical perspective

  2016cites this paper
• SYSTOLIC BLOOD PRESSURE IS A VALID MARKER OF IN-HOSPITAL SURVIVAL IN ACUTE CARDIOGENIC PULMONARY EDEMA - ANALYSIS OF 1.397 PATIENTS

  2015cites this paper